Results For "IDVYNSO"

1 News Found

US FDA okays Merck's new once-daily HIV pill

Drug Approval | April 22, 2026

US FDA okays Merck's new once-daily HIV pill

The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir

Latest Stories

Crown Bioscience partners with Turbine to accelerate translational oncology research

ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer

New brain study reveals why alcohol relapse remains a persistent challenge

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews

We believe in trust-driven clinical conversations to cut through medical misinformation: Sourav Kasera, Founder, CLIRNET

We believe in trust-driven clinical conversations to cut through medical misinformation: Sourav Kasera, Founder, CLIRNET

Sourav Kasera Founder, CLIRNET

Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Packaging